The magnitude of macrophage inflammatory response does not directly depend on ability of bone marrow cells to respond to interleukin-3 in mice of different strains
- PMID: 8406688
- DOI: 10.1007/BF00916584
The magnitude of macrophage inflammatory response does not directly depend on ability of bone marrow cells to respond to interleukin-3 in mice of different strains
Abstract
The multicolony stimulating factor Interleukin-3 (IL-3) has a role in regulating the proliferation, differentiation, and survival of myeloid stem cells and committed progenitor cells within each of the myeloid lineages. It has been referred to as an emergency factor appearing following triggering of an inflammatory response. The ability of bone marrow (BM) stem cells to respond to a stimulus such as IL-3 in vitro may reflect the in vivo capacity of BM stem cells to generate newly BM-derived macrophages being recruited to an inflammatory site. Both parameters, namely the BM cell response to in vitro IL-3 treatment and the magnitude of the macrophage inflammatory response vary among inbred mouse strains. Mice of the A/J strain are known to have weak macrophage inflammatory response to a phlogistic agent and their BM cells are hyporesponsive to IL-3 exposure. In contrast, mice of the C57BL/6 strain mount a high macrophage inflammatory reaction to a stimulus, and their BM cells strongly proliferate in response to the presence of IL-3. Thus, we examined whether or not the type of BM cell response to IL-3 (i.e., A/J- or C57BL/6-like) determines the magnitude of the macrophage inflammatory response using the A x B/B x A recombinant inbred (RI) mouse strain system. The two traits were found not to cosegregate, suggesting that they are not linked. The continuous strain distribution pattern of the magnitude of the macrophage inflammatory response obtained in mice of the A x B/B x A RI strains implies that this trait is under the control of several genes.
Similar articles
-
Bone marrow cell response following induction of acute inflammation in different strains of mice.Inflammation. 1993 Dec;17(6):677-85. doi: 10.1007/BF00920473. Inflammation. 1993. PMID: 8112827
-
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).Bone Marrow Transplant. 1989 Sep;4(5):459-64. Bone Marrow Transplant. 1989. PMID: 2676042
-
Interleukin 3 alone does not support the proliferation of bone marrow cells from A/J mice: a novel system for studying the synergistic activities of IL-3.Br J Haematol. 1990 Feb;74(2):131-7. doi: 10.1111/j.1365-2141.1990.tb02555.x. Br J Haematol. 1990. PMID: 2138495
-
The effects of interleukin 3 (IL-3) on cells responsive to macrophage colony-stimulating factor (CSF-1) in liquid murine bone marrow culture.Br J Haematol. 1990 Feb;74(2):138-45. doi: 10.1111/j.1365-2141.1990.tb02556.x. Br J Haematol. 1990. PMID: 2180468
-
Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.Exp Hematol. 1992 Feb;20(2):201-8. Exp Hematol. 1992. PMID: 1371965
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases